AMPLIFY - D6571C00001 Duaklir USA Phase III Study

Clinical trial NCT02796677 · COMPLETED

Trial details

NCT number: NCT02796677
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2016-07-05
Primary completion: 2017-06-08
Enrollment: 1595

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.